95 results
8-K
EX-99.4
GMDAQ
Gamida Cell Ltd
24 May 24
In the United States Bankruptcy Court for the District of Delaware
10:45am
in section 2(a)(1) of the Securities Act.
97. “Senior Secured Agent” means Wilmington Savings Fund Society, FSB, in its capacity as administrative agent … to the Petition Date.
110. “Unsecured Notes Trustee” means Wilmington Savings Fund Society, FSB, in its capacity as trustee under the Unsecured Notes
8-K
GMDAQ
Gamida Cell Ltd
24 May 24
In the United States Bankruptcy Court for the District of Delaware
10:45am
Savings Fund Society, FSB, as collateral agent and administrative agent and (iii) $15 million of additional commitments to be funded by way of delayed
8-K/A
EX-99.1
GMDAQ
Gamida Cell Ltd
5 Apr 24
Other Events
5:16pm
results from the Phase 1 clinical study at the Annual Meeting of the American Society of Hematology, or ASH. The data from the first 35 patients … Society of Hematology the Company reported two-year follow-up data from this clinical trial on outcomes and cytokine biomarkers associated
8-K
EX-10.1
s9eacghc1xj46672t
27 Mar 24
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
7:30am
8-K
EX-99.1
r75lk n5cwr
27 Mar 24
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
7:30am
8-K
EX-99.1
icbvcd mxf
14 Nov 23
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
12:00am
8-K
EX-99.1
czrvqddx
14 Aug 23
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
7:30am
DEFR14A
qjka7e23l6cepb2
9 May 23
Revised proxy
5:25pm
8-K
EX-4.1
1zkm 197dcxl
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
424B5
g91d9y4cx9kh3itzp
20 Apr 23
Prospectus supplement for primary offering
5:27pm
424B5
ba9yd6
19 Apr 23
Prospectus supplement for primary offering
6:46am
8-K
EX-99.1
mybm9h
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm